These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 9657513)

  • 1. Efficacy and safety of CGP 56697 (artemether and benflumetol) compared with chloroquine to treat acute falciparum malaria in Tanzanian children aged 1-5 years.
    Hatz C; Abdulla S; Mull R; Schellenberg D; Gathmann I; Kibatala P; Beck HP; Tanner M; Royce C
    Trop Med Int Health; 1998 Jun; 3(6):498-504. PubMed ID: 9657513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized, double-blind, parallel-group, comparative safety, and efficacy trial of oral co-artemether versus oral chloroquine in the treatment of acute uncomplicated Plasmodium falciparum malaria in adults in India.
    Kshirsagar NA; Gogtay NJ; Moorthy NS; Garg MR; Dalvi SS; Chogle AR; Sorabjee JS; Marathe SN; Tilve GH; Bhatt AD; Sane SP; Mull R; Gathmann I
    Am J Trop Med Hyg; 2000 Mar; 62(3):402-8. PubMed ID: 11037786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of African children with uncomplicated falciparum malaria with a new antimalarial drug, CGP 56697.
    von Seidlein L; Jaffar S; Pinder M; Haywood M; Snounou G; Gemperli B; Gathmann I; Royce C; Greenwood B
    J Infect Dis; 1997 Oct; 176(4):1113-6. PubMed ID: 9333180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of six doses of artemether-lumefantrine (benflumetol) in multidrug-resistant Plasmodium falciparum malaria.
    Vugt MV; Wilairatana P; Gemperli B; Gathmann I; Phaipun L; Brockman A; Luxemburger C; White NJ; Nosten F; Looareesuwan S
    Am J Trop Med Hyg; 1999 Jun; 60(6):936-42. PubMed ID: 10403324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinction of recrudescences from new infections by PCR-RFLP analysis in a comparative trial of CGP 56 697 and chloroquine in Tanzanian children.
    Irion A; Felger I; Abdulla S; Smith T; Mull R; Tanner M; Hatz C; Beck HP
    Trop Med Int Health; 1998 Jun; 3(6):490-7. PubMed ID: 9657512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison.
    Ratcliff A; Siswantoro H; Kenangalem E; Maristela R; Wuwung RM; Laihad F; Ebsworth EP; Anstey NM; Tjitra E; Price RN
    Lancet; 2007 Mar; 369(9563):757-765. PubMed ID: 17336652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized comparison of chloroquine plus sulfadoxine-pyrimethamine versus artesunate plus mefloquine versus artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in the Lao People's Democratic Republic.
    Mayxay M; Khanthavong M; Lindegårdh N; Keola S; Barends M; Pongvongsa T; Yapom R; Annerberg A; Phompida S; Phetsouvanh R; White NJ; Newton PN
    Clin Infect Dis; 2004 Oct; 39(8):1139-47. PubMed ID: 15486837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, double-blind, comparative trial of a new oral combination of artemether and benflumetol (CGP 56697) with mefloquine in the treatment of acute Plasmodium falciparum malaria in Thailand.
    Looareesuwan S; Wilairatana P; Chokejindachai W; Chalermrut K; Wernsdorfer W; Gemperli B; Gathmann I; Royce C
    Am J Trop Med Hyg; 1999 Feb; 60(2):238-43. PubMed ID: 10072142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An integrated assessment of the clinical safety of artemether-lumefantrine: a new oral fixed-dose combination antimalarial drug.
    Bakshi R; Hermeling-Fritz I; Gathmann I; Alteri E
    Trans R Soc Trop Med Hyg; 2000; 94(4):419-24. PubMed ID: 11127248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of artesunate plus amodiaquine versus that of artemether-lumefantrine for the treatment of uncomplicated childhood Plasmodium falciparum malaria in Zanzibar, Tanzania.
    Mårtensson A; Strömberg J; Sisowath C; Msellem MI; Gil JP; Montgomery SM; Olliaro P; Ali AS; Björkman A
    Clin Infect Dis; 2005 Oct; 41(8):1079-86. PubMed ID: 16163624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Artemether-lumefantrine for the treatment of multidrug-resistant falciparum malaria.
    van Vugt M; Looareesuwan S; Wilairatana P; McGready R; Villegas L; Gathmann I; Mull R; Brockman A; White NJ; Nosten F
    Trans R Soc Trop Med Hyg; 2000; 94(5):545-8. PubMed ID: 11132386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II trial in China of a new, rapidly-acting and effective oral antimalarial, CGP 56697, for the treatment of Plasmodium falciparum malaria.
    Jiao X; Liu GY; Shan CO; Zhao X; Li XW; Gathmann I; Royce C
    Southeast Asian J Trop Med Public Health; 1997 Sep; 28(3):476-81. PubMed ID: 9561595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Supervised versus unsupervised intake of six-dose artemether-lumefantrine for treatment of acute, uncomplicated Plasmodium falciparum malaria in Mbarara, Uganda: a randomised trial.
    Piola P; Fogg C; Bajunirwe F; Biraro S; Grandesso F; Ruzagira E; Babigumira J; Kigozi I; Kiguli J; Kyomuhendo J; Ferradini L; Taylor W; Checchi F; Guthmann JP
    Lancet; 2005 Apr 23-29; 365(9469):1467-73. PubMed ID: 15850630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The comparative efficacy and tolerability of CGP 56697 (artemether + lumefantrine) versus halofantrine in the treatment of uncomplicated falciparum malaria in travellers returning from the Tropics to The Netherlands and France.
    van Agtmael M; Bouchaud O; Malvy D; Delmont J; Danis M; Barette S; Gras C; Bernard J; Touze JE; Gathmann I; Mull R
    Int J Antimicrob Agents; 1999 Jul; 12(2):159-69. PubMed ID: 10418762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A clinical and pharmacokinetic trial of six doses of artemether-lumefantrine for multidrug-resistant Plasmodium falciparum malaria in Thailand.
    Lefèvre G; Looareesuwan S; Treeprasertsuk S; Krudsood S; Silachamroon U; Gathmann I; Mull R; Bakshi R
    Am J Trop Med Hyg; 2001; 64(5-6):247-56. PubMed ID: 11463111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Similar efficacy and tolerability of double-dose chloroquine and artemether-lumefantrine for treatment of Plasmodium falciparum infection in Guinea-Bissau: a randomized trial.
    Ursing J; Kofoed PE; Rodrigues A; Blessborn D; Thoft-Nielsen R; Björkman A; Rombo L
    J Infect Dis; 2011 Jan; 203(1):109-16. PubMed ID: 21148503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coartemether (artemether and lumefantrine): an oral antimalarial drug.
    Wernsdorfer WH
    Expert Rev Anti Infect Ther; 2004 Apr; 2(2):181-96. PubMed ID: 15482185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amodiaquine alone, amodiaquine+sulfadoxine-pyrimethamine, amodiaquine+artesunate, and artemether-lumefantrine for outpatient treatment of malaria in Tanzanian children: a four-arm randomised effectiveness trial.
    Mutabingwa TK; Anthony D; Heller A; Hallett R; Ahmed J; Drakeley C; Greenwood BM; Whitty CJ
    Lancet; 2005 Apr 23-29; 365(9469):1474-80. PubMed ID: 15850631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized comparison of artemether-benflumetol and artesunate-mefloquine in treatment of multidrug-resistant falciparum malaria.
    van Vugt M; Brockman A; Gemperli B; Luxemburger C; Gathmann I; Royce C; Slight T; Looareesuwan S; White NJ; Nosten F
    Antimicrob Agents Chemother; 1998 Jan; 42(1):135-9. PubMed ID: 9449273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of artemether-lumefantrine (Coartem) tablets (six-dose regimen) in African infants and children with acute, uncomplicated falciparum malaria.
    Falade C; Makanga M; Premji Z; Ortmann CE; Stockmeyer M; de Palacios PI
    Trans R Soc Trop Med Hyg; 2005 Jun; 99(6):459-67. PubMed ID: 15837358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.